A former head of the U.S. Food and Drug Administration said Johnson & Johnson’s Janssen Pharmaceuticals unit manipulated data involving the potential safety risks associated with Risperdal treatment in children.
According to a report by Dr. David Kessler, former head of the FDA, Janssen Pharmaceuticals manipulated the findings of a 2003 study that analyzed the potential for Risperdal treatment in children to cause devastating physical injuries.
In the study, researchers concluded that there was no direct link between elevated prolactin levels caused by Risperdal use and breast growth in boys and young men, a condition known as gynecomastia.
Dr. Kessler claims that accurate information about the link between Risperdal and gynecomastia was left out of the 2003 study, published in the Journal of Clinical Psychiatry, when the research findings were edited by the Janssen employees who co-authored the study.
Revelations about the misleading Risperdal gynecomastia data came about as a result of the growing number of Risperdal lawsuits brought against Johnson & Johnson over male breast growth and other complications allegedly caused by the drug.
Roughly 1,300 Risperdal gynecomastia lawsuits are pending in Pennsylvania state court, all of which involve similar allegations that J&J failed to provide adequate warnings about the risks of Risperdal use among male children.
Risperdal Study Data Manipulated
In recent testimony provided by Dr. Kessler, who is also a pediatrician, the former FDA commissioner indicates that Janssen Pharmaceuticals manipulated more than 40 manuscripts and understated the risk of Risperdal side effects in young boys, claims echoed by Dr. Dennis Daneman, top pediatrician at SickKids hospital in Canada and co-author of the 2003 Risperdal study.
The testimony comes just a year after a class action lawsuit was filed against Janssen Pharmaceuticals over its alleged manipulation of Risperdal clinical trial data, accusing the company of downplaying Risperdal health risks and writing misleading media articles in support of the medication.
In response to these claims of manipulation, Daneman and another researcher involved in the original 2003 study are having the Risperdal side effect data reexamined by an independent biostatistician, after which they will either issue a retraction of the research or provide corrections based on the new findings.
Risperdal (risperidone) is FDA-approved to treat adults and children with schizophrenia, bipolar disorder and irritability with autism. It is also often prescribed off label for behavior problems including ADHD and ADD.
Medications are approved by the FDA for uses based on safety and efficacy data provided by drug companies. The FDA determined that drugs like Risperdal can be effective for treating adults and children, and the agency has also identified potential side effects based on these studies.
If you or a loved one has suffered serious Risperdal side effects, contact a knowledgeable product liability lawyer today for legal help.
Do YOU have a legal claim? Fill out the form on this page now for a free, immediate, and confidential case evaluation. The Risperdal attorneys who work with Top Class Actions will contact you if you qualify to let you know if an individual lawsuit or Risperdal class action lawsuit is best for you. [In general, Risperdal lawsuits are filed individually by each plaintiff and are not class actions.] Hurry — statutes of limitations may apply.
Top Class Actions is a Proud Member of the American Bar Association
LEGAL INFORMATION IS NOT LEGAL ADVICE
Top Class Actions Legal Statement
©2008 – 2015 Top Class Actions® LLC
Various Trademarks held by their respective owners
Get Help – It’s Free
Join a Free Risperdal Class Action Lawsuit Investigation
If you or your son took Risperdal between the ages of 10 and 18 years old and suffered gynecomastia (male breast growth), male breast pain, nipple pain, or nipple discharge, you may be entitled to compensation. See if you qualify by submitting your information below for a free and confidential case review.
An attorney will contact you if you qualify to discuss the details of your potential case at no charge to you.
- First Name*
- Last Name*
- Street Address*
- Apt. #
- City*
- State*
AlabamaAlaskaArizonaArkansasCaliforniaColoradoConnecticutDelawareDistrict of ColumbiaFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaOhioOklahomaOregonPennsylvaniaRhode IslandSouth CarolinaSouth DakotaTennesseeTexasUtahVermontVirginiaWashingtonWest VirginiaWisconsinWyomingArmed Forces AmericasArmed Forces EuropeArmed Forces Pacific
- Zip Code*
- Phone*
- Email*
- If you're filling this out for a loved one, what is the name of the person who took Risperdal?*
- Are you/your loved one a male who took Risperdal between the ages of 10 and 18 years old?*
YesNo
- What year was the person who took Risperdal born?*
- How old was this person when they took Risperdal?*
- Please check the Risperdal injuries suffered:*
-
Breast Growth
-
Breast Pain
-
Nipple Pain
-
Nipple Discharge
-
- How old were you/your loved one when these problems began?*
- ¿Necesita un orador español?
- Yes
- No
- Please enter any additional details you would like the staff reviewing your submission to know.
- I understand and agree that submitting this form does not create an attorney-client relationship and that the information I submit is not confidential or privileged and may be shared.*
-
Yes
-
-
if(typeof gf_global == ‘undefined’) var gf_global = {“gf_currency_config”:{“name”:”U.S. Dollar”,”symbol_left”:”$”,”symbol_right”:””,”symbol_padding”:””,”thousand_separator”:”,”,”decimal_separator”:”.”,”decimals”:2},”base_url”:”http:\/\/topclassactions.com\/wp-content\/plugins\/gravityforms”,”number_formats”:[],”spinnerUrl”:”http:\/\/topclassactions.com\/wp-content\/plugins\/gravityforms\/images\/spinner.gif”};jQuery(document).bind(‘gform_post_render’, function(event, formId, currentPage){if(formId == 25) {gformInitChosenFields(‘#input_25_5′,’No results matched’);if(!/(android)/i.test(navigator.userAgent)){jQuery(‘#input_25_7’).mask(‘(999) 999-9999’).bind(‘keypress’, function(e){if(e.which == 13){jQuery(this).blur();} } );}} } );jQuery(document).bind(‘gform_post_conditional_logic’, function(event, formId, fields, isInit){gformInitChosenFields(‘#input_25_5′,’No results matched’);} ); jQuery(document).ready(function(){jQuery(document).trigger(‘gform_post_render’, [25, 1]) } );
The post Former FDA Director Says Janssen Manipulated Risperdal Data appeared first on Top Class Actions.
No comments:
Post a Comment